Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Personalis Inc (NQ: PSNL )

5.680 -0.250 (-4.22%)
Streaming Delayed Price Updated: 11:59 AM EDT, Sep 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Personalis Inc

< Previous 1 2 3 4 5 6 7 Next >
Personalis to Participate at the 6th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
From Personalis, Inc.
Via Business Wire
Personalis, Inc. Publishes New Data Demonstrating a Novel Composite Biomarker NEOPS™ for Predicting Response to Cancer Immunotherapy in Late-Stage Melanoma Patients
From Personalis, Inc.
Via Business Wire
Personalis to Announce Second Quarter Financial Results on August 4, 2021
From Personalis, Inc.
Via Business Wire
Personalis Announces NeXT Level Biomarkers Symposium
From Personalis, Inc.
Via Business Wire
Personalis Announces Delivery of the 125,000th Genome to the U.S. Department of Veterans Affairs Million Veteran Program
From Personalis, Inc.
Via Business Wire
Personalis to Participate at the Oppenheimer MedTech, Tools & Diagnostics Summit
From Personalis, Inc.
Via Business Wire
Personalis, Inc. to Present at Biomarkers Week Online 2021
From Personalis, Inc.
Via Business Wire
Personalis Reports First Quarter 2021 Financial Results
From Personalis, Inc.
Via Business Wire
Personalis to Present at the 2021 Bank of America Healthcare Conference
From Personalis, Inc.
Via Business Wire
Personalis to Report First Quarter 2021 Financial Results on May 5, 2021
From Personalis, Inc.
Via Business Wire
Personalis Presents Data at AACR Annual Meeting 2021 Showcasing the Personalis ImmunoID NeXT Platform®
From Personalis, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.